Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 670.5 JPY 0.39% Market Closed
Market Cap: 606.7B JPY
Have any thoughts about
Santen Pharmaceutical Co Ltd?
Write Note

Santen Pharmaceutical Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Santen Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Santen Pharmaceutical Co Ltd
TSE:4536
Interest Income Expense
-ÂĄ8.5B
CAGR 3-Years
-117%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Interest Income Expense
-ÂĄ175.7B
CAGR 3-Years
-15%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Interest Income Expense
ÂĄ24.3B
CAGR 3-Years
100%
CAGR 5-Years
60%
CAGR 10-Years
8%
Otsuka Holdings Co Ltd
TSE:4578
Interest Income Expense
ÂĄ20.5B
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
6%
Chugai Pharmaceutical Co Ltd
TSE:4519
Interest Income Expense
ÂĄ39m
CAGR 3-Years
-54%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Interest Income Expense
-ÂĄ1.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-2%
No Stocks Found

Santen Pharmaceutical Co Ltd
Glance View

Market Cap
594.1B JPY
Industry
Pharmaceuticals

Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. The company is headquartered in Osaka, Osaka-Fu and currently employs 4,229 full-time employees. The firm has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The firm engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The firm operates in Japan, Europe, Asia, North America markets.

Intrinsic Value
2 142.23 JPY
Undervaluation 22%
Intrinsic Value
Price

See Also

What is Santen Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
-8.5B JPY

Based on the financial report for Jun 30, 2024, Santen Pharmaceutical Co Ltd's Interest Income Expense amounts to -8.5B JPY.

What is Santen Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-39%

Over the last year, the Interest Income Expense growth was -155%. The average annual Interest Income Expense growth rates for Santen Pharmaceutical Co Ltd have been -117% over the past three years , -39% over the past five years .

Back to Top